Strand Life Sciences

second logo

+91 96866 01656

hello@strandls.com

  • About Us
  • Clinical Diagnostics
  • Bioinformatics
  • Clinical Research
  • Book a test
  • About Us
  • Clinical Diagnostics
  • Bioinformatics
  • Clinical Research
  • Book a test
  • Home
  • Easy Test for Cancer?? How about a simple blood draw?
  • June 2018

June 2018

Easy Test for Cancer?? How about a simple blood draw?

admin2021-06-13T20:13:15+05:30

Diagnosing cancers is not easy! Doctors rely on the symptoms presented by the patient, biochemical diagnostic tests and results of imaging techniques like ultrasonography (USG), magnetic resonance imaging (MRI), positron emission tomography (PET) and computed tomography (CT) to diagnose various kinds of solid tumors. The only problem with this approach...

Read more...

Retinoblastoma

admin2021-06-13T20:13:54+05:30

Close your eyes for 30 seconds. Now try walking around your room or home for five minutes. Bet you stumbled against furniture that you already KNOW, is in place! Can you imagine how difficult life must be for the visually challenged?? One of the ways we lose our vision...

Read more...

Strand Launches Liquid Biopsy Tests For Cancer – Medical Innovation Made In India

admin2021-06-13T20:13:58+05:30

Standing from left to right: Dr. Ramesh Hariharan, Dr. Vijay Chandru, Kiran Mazumdar Shaw, Dr. Sharath Damodhar, and Dr. Aditya Chaubey launching Strand LB test portfolio. by Dr. Rashmi Chaturvedi Upadhyay Four years of extensive research studies alongside stringent validation runs made it possible for scientists at Strand Life Science to...

Read more...

Using Liquid Biopsy To Monitor Colorectal Cancer

admin2021-06-13T20:09:52+05:30

by Dr. Rashmi Chaturvedi Upadhyay What is colorectal cancer? Colorectal cancer encompasses both cancers of the colon and the rectum. According to the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC), it is the second most common cancer worldwide after lung cancer. Colon cancer and rectal...

Read more...

Liquid Biopsy: A Paradigm Shift in Monitoring Cancer

admin2021-06-13T20:14:02+05:30

Guest Author: Dr. Vijay Chandru Chairman and Managing Director, Strand Life Sciences Diagnosis, administration of chemo- or radiotherapy, a wait-and-watch approach for new clinical symptoms of cancer (6-12 months) and fresh rounds of chemo- and radiotherapy is the established pattern of cancer care. More often than not, the waiting period for...

Read more...

Liquid Biopsy Provides An Accurate Snapshot Of Cancer

admin2021-06-13T20:14:06+05:30

Liquid Biopsy! This buzzword is being bandied around quite a bit these days. It’s the latest and supposedly a very important diagnostic test for cancer. How exactly, do you ask? Here goes. Typically, a tissue sample of all kinds of cancers is required to understand the type and nature of...

Read more...

DNA Analysis Provides Accurate Diagnosis of A Birth Defect

admin2021-06-13T20:14:10+05:30

Rare diseases, as the name suggests, are found at a low frequency in any country or population set. Now, because the diseases occur at a low frequency, the opportunities to study them in detail are therefore scarce. Hence, the diagnosis of such disorders is not easy. Some symptoms like...

Read more...

A Crash Course in Genetics Lingo

admin2021-06-13T20:14:13+05:30

Genetic testing is a new diagnostic tool that your doctors may use for diagnosis of cancer in you or your kith and kin. Although the current tests are meant for confirming diagnoses of cancer and for supporting choice of chemotherapy drugs, the day is not far off when a...

Read more...

Media Open Day at Strand’s NGS Laboratories

admin2021-06-13T20:09:58+05:30

Last week, we invited journalists from regional and national media to learn more about genetic testing, cancer, and hereditary cancer in particular. Several journalists showed keen interest in what Dr. Sudhir Borgonha, Chief Medical Officer at Strand Life Sciences, had to say about the genetic nature of cancer and...

Read more...

Preventive Screening for Ovarian Cancer: A Genetic Profile Is The Most Reliable Risk Predictor

admin2021-06-13T20:14:51+05:30

Ovarian cancer is the fifth most lethal cancer of women, in USA and UK. In India, however, it is the third most lethal cancer in women. What is most worrisome is that an increase in the incidence of ovarian cancer in India is noted in women younger than 60...

Read more...
  Prev123…5Next  

Company

Board
Team
Our Journey
Press Releases
Blog

Accreditation

Strand Center for Genomics and Personalized Medicine and Strand’s laboratory in HCG’s
Center of Excellence in
Bangalore are accredited by

Community Newsletter

Past Issues

SUBSCRIBE

Physician Newsletter

Past Issues

SUBSCRIBE

Contact us

Careers

Privacy policy

© Strand Life Sciences 2021 - All Rights Reserved

Feedback